Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etonogestrel Implant + Testosterone Undecanoate for Male Contraception
NCT00403793Phase 2Completed
- Sponsor
- Organon & Co.
- Start
- Oct 2003
- Primary completion
- Dec 2006
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of etonogestrel, testosterone undecanoate in contraception, sponsored by Organon & Co.. Started Oct 2003; status: completed.
02
Drugs
etonogestreltestosterone undecanoate
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00403793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403793.